PRLD
Prelude Therapeutics Incorporated
$1.01
+$0.03(+2.56%)
18
Overall
--
Value
18
Tech
--
Quality
Market Cap
$65.66M
Volume
180.26K
52W Range
$0.61 - $2.56
Target Price
$3.50
EPS Estimates Overview
| Current Quarter | $-0.46 | Next Quarter | $-0.28 |
| Current Year | $-1.59 | Next Year | $-1.36 |
| QoQ Growth | +39.1% | YoY Growth | +14.5% |
| 3Y EPS CAGR | +11.6% | Target Price | $3.50 |
| Consensus | Buy | Upside | +246.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRLD | $1.01 | +2.6% | 180.26K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Prelude Therapeutics Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW